List of bibliographic references
Number of relevant bibliographic references: 11.
| Ident. | Authors (with country if any) | Title |
|---|
| 000E37 (2004) |
Kalman Magyar ; Béla Szende | (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties |
| 000E38 (2004) |
Toshiharu Nagatsu | Progress in monoamine oxidase (MAO) research in relation to genetic engineering |
| 000E39 (2004) |
JEAN CHEN SHIN | Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B |
| 000E40 (2004) |
N. Hamaue ; M. Minami ; M. Terado ; M. Hirafuji ; T. Endo ; M. Machida ; T. Hiroshige ; A. Ogata ; K. Tashiro ; H. Saito ; S. H. Parvez | Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus |
| 000E41 (2004) |
Moussa B. H. Youdim ; Marta Weinstock | Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation |
| 000E42 (2004) |
Kay Castagnoli ; Thangaraju Murugesan | Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links? |
| 000E43 (2004) |
William J. Burke ; SHU WEN LI ; Hyung D. Chung ; David A. Ruggiero ; Bruce S. Kristal ; Eugene M. Johnson ; Patricia Lampe ; Vijaya B. Kumar ; Mark Franko ; Evelyn A. Williams ; Daniel S. Zahm | Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases |
| 000E44 (2004) |
Michael A. Collins | Tetrahydropapaveroline in Parkinson's disease and alcoholism: A look back in honor of Merton Sandler |
| 000E45 (2004) |
Peter Riederer ; Walter Danielczyk ; Edna Grünblatt | Monoamine oxidase-B inhibition in Alzheimer's disease |
| 000E46 (2004) |
Makoto Naoi ; Wakako Maruyama ; Georgy M. Nagy | Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brains |
| 000E47 (2004) |
Mitsuhiko Yamada ; Hajime Yasuhara | Clinical pharmacology of MAO inhibitors: Safety and future |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/FA12s1.i -k "PARVEZ (S.)"
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/FA12s1.i \
-Sk "PARVEZ (S.)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PascalFrancis
|étape= Corpus
|type= indexItem
|index= FA12s1.i
|clé= PARVEZ (S.)
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
